FDA approves new drug to treat advanced breast cancer

test tubes - pixabay - research

The Food and Drug Administration has approved Piqray (alpelisib) tablets to treat men and postmenopausal women whose advanced breast cancer is hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative and PIK3CA-mutated.

Piqray is to be used in combination with the FDA-approved endocrine therapy fulvestrant. TheĀ PIK3CA-mutated, advanced or metastatic breast cancer (as detected by an FDA-approved test) is indicated following progression on or after an endocrine-based regimen.

Continue reading “FDA approves new drug to treat advanced breast cancer”